← Open Payments lookup

ANGENETTE HAYES: Open Payments

NPI 1780318519 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$702 in 9 payments from 6 companies in 2025. Trend: 2023 $389 · 2024 $762 · 2025 $702

Food & beverage: $702
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.3$378
Axsome Therapeutics, Inc.1$122
Teva Pharmaceuticals USA, Inc.1$119
Indivior Inc.2$42
ABBVIE INC.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: COBENFY, Auvelity, AUSTEDO XR, SUBLOCADE, VRAYLAR, CAPLYTA.

Industry payments across MD — which companies pay providers there.